Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intra-hepatic oxaliplatin and systemic capecitabine in liver-only metastatic breast cancer
NCT01387373Phase 2Completed
- Start
- Apr 2010
- Primary completion
- May 2017
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of oxaliplatin in breast cancer, liver metastases. Started Apr 2010; status: completed.
02
Drugs
oxaliplatin
03
Conditions
breast cancerliver metastases
Beyond the preview
Go deeper on NCT01387373.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01387373.